Topical Drug Delivery Market Analysis 2018 to 2024 - Technological Advancements and Innovations the +9.2% CAGR Industry

Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired unfavourable effect of a drug is dependent on the concentration of the drug at the place of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action.

Avail 10% discount on direct purchase kindly send the email @ sopan.gedam@databridgemarketresearch.com

Segmentation:

The global topical drug delivery market is segmented on the basis of product type, indication, distribution channel, end user and geography.

On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations. Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories. The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.

The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others. In 2017, anti-acne is expected to dominate the market with the highest market share in the forecast period 2017 to 2024.

Request for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market

On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others. In 2017, the hospitals segment is expected to dominate the global topical drug delivery devices market with more than 40% market share.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Major Players:

Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals. Some of the other players in the global topical drug delivery market are MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company), Crescita Therapeutics, West Pharmaceutical Services, Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation, Skinvisible Pharmaceuticals, Inc., Mylan Pharmaceuticals Inc., Pocono Coated Products LLC, TheraSolve NV., Samyang Biopharmaceuticals Corporation, Lohmann Therapie-Systeme AG, Prosollus Pharmaceuticals, Easton Pharmaceuticals Inc., Novosis AG, Endo Pharmaceuticals Inc., Transdermal Technologies, Inc., Sheffield Pharmaceuticals, Inc., and Solvay among others.

Inquiry about this Report @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market

Drivers:

Some of the major factors driving the topical drug delivery market are ability to deliver drug at the desired site, inter-and intra-patient variations, without fluctuations in drug levels, an enhanced suitability for self-medication and improved compliance. Also, increasing aging population, growing prevalence of skin related ailments and rising prevalence of chronic diseases, also new and better technologies for topical drug delivery is expected to boost the growth of this market are the major factors driving the growth of the injectable drug delivery market.

RISING CASES OF ACUTE AND CHRONIC DISEASES

The prevalence of diseases and conditions such as infections which includes bacterial infection and fungal infections, inflammations, pain management, acne, sun burns, psoriasis, dermatitis, skin allergy, skin cancer, diabetes, and many others has increased considerably over a period of time.

RISING AGING POPULATION

With the increasing age, the cases of acute and chronic diseases are rising. Older population is more prone to diseases such as diabetes, allergy, arthritis, infections, and dermatitis.

TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS

With the rising prevalence of acute and chronic diseases it has become important for the drug and device manufacturers to develop advanced technologies that will provide more effective treatment for the diseases. In the few years, many developments took place for the topical drug delivery due to the rapid absorption of drugs.

APPROVAL OF NEW DRUGS

With the increasing demand for the treatment of diseases using painless and non-invasive method the demand for topical drug delivery is increasing.

BETTER OPPORTUNITY IN PHARMERGING MARKETS

According to Data Bridge Market Research analysts, Japan, Europe and North America are expected to account for around 73% of total global pharmaceutical market, while the rest of the world only own 27% of the market.

Read more about the Global Topical Drug Delivery Market @ http://databridgemarketresearch.com/reports/global-topical-drug-delivery-market/

TABLE OF CONTENTS GLOBAL TOPICAL DRUG DELIVERY MARKET

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL TOPICAL DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE
3.1.2. RISING AGING POPULATION
3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS
3.1.4. APPROVAL OF NEW DRUGS
3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE

3.3. OPPORTUNITY

3.3.1. ENERGING MARKET
3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS

3.4. CHALLENGES

3.4.1. PRODUCT RECALL
3.4.2. PENETRATION INTO THE SMALLER MARKETS

4. PREMIUM INSIGHTS

5. EXECUTIVE SUMMARY

6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE

6.1. OVERVIEW

6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS)
6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE
6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE

7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION

7.1. OVERVIEW
7.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.3. GLOBAL ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION

8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

8.1. OVERVIEW
8.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER

9.1. OVERVIEW

10. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY

10.1. OVERVIEW

10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET
10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET
10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET

10.3. EUROPE TOPICAL DRUG DELIVERY MARKET

10.3.1. GERMANY TOPICAL DRUG DELIVERY MARKET
10.3.2. FRANCE TOPICAL DRUG DELIVERY MARKET
10.3.3. ITALY TOPICAL DRUG DELIVERY MARKET
10.3.4. U.K. TOPICAL DRUG DELIVERY MARKET
10.3.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET
10.3.6. SPAIN TOPICAL DRUG DELIVERY MARKET
10.3.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET
10.3.8. RUSSIA TOPICAL DRUG DELIVERY MARKET
10.3.9. TURKEY TOPICAL DRUG DELIVERY MARKET
10.3.10. BELGIUM TOPICAL DRUG DELIVERY MARKET
10.3.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET

10.4. APAC TOPICAL DRUG DELIVERY MARKET

10.4.1. JAPAN TOPICAL DRUG DELIVERY MARKET
10.4.2. CHINA TOPICAL DRUG DELIVERY MARKET
10.4.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET
10.4.4. INDIA TOPICAL DRUG DELIVERY MARKET
10.4.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET
10.4.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET
10.4.7. THAILAND TOPICAL DRUG DELIVERY MARKET
10.4.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET
10.4.9. INDONESIA TOPICAL DRUG DELIVERY MARKET
10.4.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET
10.4.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET

10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.5.1. BRAZIL TOPICAL DRUG DELIVERY MARKET
10.5.2. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.6. MIDDLE EAST AND AFRICA (MEA) TOPICAL DRUG DELIVERY MARKET

10.6.1. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET
10.6.2. REST OF MEA TOPICAL DRUG DELIVERY MARKET

11. GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE

11.1. COMPANY SHARE ANALYSIS: GLOBAL

12. COMPANY PROFILES

12.1. GALDERMA PHARMA S.A.

12.1.1. COMPANY OVERVIEW
12.1.2. FINANCIAL OVERVIEW
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS

12.2. HISAMITSU PHARMACEUTICAL CO., INC.

12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS

12.3. PFIZER INC.

12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS

12.4. ABBVIE INC.

12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS

12.5. BAYER AG

12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS

12.6. 3M

12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS

12.7. ANTARES PHARMA, INC.

12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS

12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS

12.9. ALLERGAN PLC.

12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS

12.10. KAKEN PHARMACEUTICALS CO., LTD

12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/medical-devices/ablation-devices-medical-devices/global-tumour-ablation-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Ankit Singh
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.